FCMI
JNCE

Foresite Capital Management II’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Foresite Capital Management II’s Portfolio JNCE Stock Details JNCE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
2017
Q3 		$1.87M Hold
2017
Q2 		$1.68M Hold
2017
Q1 		$2.64M Buy